Focal therapy for prostate cancer: The current status

Prostate International

Volumn 3, Issue 2, 2015, Pages 35-41

  Marshall, Susan ^a   Taneja, Samir ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ablation; Focal therapy; Fusion prostate biopsy; MRI; MRI targeted prostate biopsy; Prostate cancer

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER THERAPY; CRYOTHERAPY; FOCAL THERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HIGH RISK PATIENT; HUMAN; IMAGE GUIDED BIOPSY; LOW RISK PATIENT; MALE; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

EID: 84942121534     PISSN: 22878882     EISSN: 2287903X     Source Type: Journal    
DOI: 10.1016/j.prnil.2015.03.007     Document Type: Review

References (59)

1. T.A. Stamey, M. Caldwell, J.E. McNeal, R. Nolley, M. Hemenez, and J. Downs The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 172 2004 1297 1301
2. E.W. Steyerberg, M.J. Roobol, M.W. Kattan, T.H. van der Kwast, H.J. de Koning, and F.H. Schroder Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram J Urol 177 2007 107 112
3. L. Klotz, L. Zhang, A. Lam, R. Nam, A. Mamedov, and A. Loblaw Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
4. A.S. Duffield, T.K. Lee, H. Miyamoto, H.B. Carter, and J.I. Epstein Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2009 2274 2278
5. W. Liu, S. Laitinen, S. Khan, and et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer Nat Med 15 2009 559 565
6. H.U. Ahmed The index lesion and the origin of prostate cancer N Engl J Med 361 2009 1704 1706
7. A. Villers, J.E. McNeal, F.S. Freiha, and T.A. Stamey Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors Cancer 70 1992 2313 2318
8. A.M. Wise, T.A. Stamey, J.E. McNeal, and J.L. Clayton Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens Urology 60 2002 264 269
9. H.U. Ahmed, A. Freeman, A. Kirkham, and et al. Focal therapy for localized prostate cancer: a phase I/II trial J Urol 185 2011 1246 1254
10. H.U. Ahmed Focal Therapy in Prostate cancer 2012 Wiley-Blackwell Chichester
11. S.S. Taneja, and M. Mason Candidate selection for prostate cancer focal therapy J Endourol 24 2010 835 841
12. T.Y. Chan, A.W. Partin, P.C. Walsh, and J.I. Epstein Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy Urology 56 2000 823 827
13. D.V. Makarov, B.J. Trock, E.B. Humphreys, and et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (partin tables) based on cases from 2000 to 2005 Urology 69 2007 1095 1101
14. A.V. D'Amico, R. Whittington, S.B. Malkowicz, and et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer J Am Med Assoc 280 1998 969 974
15. T.A. Stamey, J.E. McNeal, C.M. Yemoto, B.M. Sigal, and I.M. Johnstone Biological determinants of cancer progression in men with prostate cancer J Am Med Assoc 281 1999 1395 1400
16. I. Thompson, J.B. Thrasher, G. Aus, and et al. Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106 2131
17. S.S. Taneja, and B. Tareen Targeting prostate cancer for focal destruction: can we find it? Cancer 113 2008 1500 1501
18. T.J. Polascik, J.M. Mayes, L. Sun, J.F. Madden, J.W. Moul, and V. Mouraviev Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy Prostate 68 2008 1380 1386
19. L.M. Boccon-Gibod, N.B. de Longchamps, M. Toublanc, L.A. Boccon-Gibod, and V. Ravery Prostate saturation biopsy in the reevaluation of microfocal prostate cancer J Urol 176 2006 961 963
20. A.S. Moussa, A. Meshref, L. Schoenfield, and et al. Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer Urology 75 2010 1034 1039
21. B.M. Mian, D.J. Lehr, C.K. Moore, and et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores Urology 67 2006 379 383
22. G. Onik, and W. Barzell Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy Urol Oncol 26 2008 506 510
23. G. Onik, M. Miessau, and D.G. Bostwick Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management J Clin Oncol 27 2009 4321 4326
24. B.G. Muller, J.J. Futterer, R.T. Gupta, and et al. The role of magnetic resonance imaging in focal therapy for prostate cancer: recommendations from a consensus panel BJU Int 113 2 2014 Feb 218 227 10.1111/bju.12243 [Epub 2013 Nov 13]
25. L. Dickinson, H.U. Ahmed, C. Allen, and et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting Eur Urol 59 2011 477 494
26. A. Villers, L. Lemaitre, J. Haffner, and P. Puech Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance Curr Opin Urol 19 2009 274 282
27. A.P. Kirkham, M. Emberton, and C. Allen How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 50 2006 1163 1174
28. S. Cirillo, M. Petracchini, P. Della Monica, and et al. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours Clin Radiol 63 2008 871 879
29. A. Tanimoto, J. Nakashima, H. Kohno, H. Shinmoto, and S. Kuribayashi Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging J Magn Reson Imaging 25 2007 146 152
30. C.M. Moore, N.L. Robertson, N. Arsanious, and et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review Eur Urol 63 2013 125 140
31. J. Haffner, L. Lemaitre, P. Puech, and et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection BJU Int 108 2011 E171 E178
32. B.K. Park, J.W. Park, S.Y. Park, and et al. Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy AJR Am J Roentgenol 197 2011 W876 W881
33. G.P. Haas, N.B. Delongchamps, R.F. Jones, and et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence J Natl Cancer Inst 99 2007 1484 1489
34. J.I. Epstein, P.C. Walsh, M. Carmichael, and C.B. Brendler Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer J Am Med Assoc 271 1994 368 374
35. G.A. Sonn, S. Natarajan, D.J. Margolis, and et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device J Urol 189 2013 86 91
36. A.R. Rastinehad, B. Turkbey, S.S. Salami, and et al. Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy J Urol 191 2013 1749 1754
37. M.M. Siddiqui, S. Rais-Bahrami, H. Truong, and et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy Eur Urol 64 2013 713 719
38. G. Onik, P. Narayan, D. Vaughan, M. Dineen, and R. Brunelle Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency Urology 60 2002 109 114
39. D.S. Ellis, T.B. Manny Jr., and J.C. Rewcastle Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results Urology 70 2007 9 15
40. E.H. Lambert, K. Bolte, P. Masson, and A.E. Katz Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer Urology 69 2007 1117 1120
41. D.K. Bahn, P. Silverman, F. Lee Sr, R. Badalament, E.D. Bahn, and J.C. Rewcastle Focal prostate cryoablation: initial results show cancer control and potency preservation J Endourol 20 2006 688 692
42. V. Mouraviev, T.E. Johansen, and T.J. Polascik Contemporary results of focal therapy for prostate cancer using cryoablation J Endourol 24 2010 827 834
43. M.D. Truesdale, P.J. Cheetham, G.W. Hruby, and et al. An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up Cancer J 16 2010 544 549
44. J.F. Ward, and J.S. Jones Focal cryotherapy for localized prostate cancer: a report from the national cryo on-line database (COLD) registry BJU Int 109 2012 1648 1654
45. S. Madersbacher, M. Pedevilla, L. Vingers, M. Susani, and M. Marberger Effect of high-intensity focused ultrasound on human prostate cancer in vivo Cancer Res 55 1995 3346 3351
46. R. Ganzer, H.M. Fritsche, A. Brandtner, and et al. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer BJU Int 112 2013 322 329
47. M. Warmuth, T. Johansson, and P. Mad Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer Eur Urol 58 2010 803 815
48. H. Lukka, T. Waldron, J. Chin, and et al. High-intensity focused ultrasound for prostate cancer: a systematic review Clin Oncol R Coll Radiol 23 2011 117 127
49. X. Rebillard, M. Soulie, E. Chartier-Kastler, and et al. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology BJU Int 101 2008 1205 1213
50. S. Muto, T. Yoshii, K. Saito, Y. Kamiyama, H. Ide, and S. Horie Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer Jpn J Clin Oncol 38 2008 192 199
51. A.B. El Fegoun, E. Barret, D. Prapotnich, and et al. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up Int Braz J Urol 37 2011 213 219
52. U. Lindner, R.A. Weersink, M.A. Haider, and et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial J Urol 182 2009 1371 1377
53. A. Oto, I. Sethi, G. Karczmar, and et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial Radiology 267 2013 932 940
54. B. Hu, L. Chen, J. Li, and J. Huang Contrast-enhanced ultrasonography evaluation of radiofrequency ablation of the prostate: a canine model J Endourol 24 2010 89 93
55. Y.Y. Chen, T. Hossack, and H. Woo Long-term results of bipolar radiofrequency needle ablation of the prostate for lower urinary tract symptoms J Endourol 25 2011 837 840
56. L. Richstone, M. Ziegelbaum, Z. Okeke, and et al. Ablation of bull prostate using novel bipolar radiofrequency ablation probe J Endourol 23 2009 11 16
57. A.P. Kirkham, M. Emberton, I.M. Hoh, R.O. Illing, A.A. Freeman, and C. Allen MR imaging of prostate after treatment with high-intensity focused ultrasound Radiology 246 2008 833 844
58. R.J. Babaian, B. Donnelly, D. Bahn, and et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer J Urol 180 2008 1993 2004
59. G. Onik, D. Vaughan, R. Lotenfoe, M. Dineen, and J. Brady The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up Urol Oncol 26 2008 500 505